Indication
Partial Epilepsy
4 clinical trials
3 products
Product
XcopriClinical trial
A Phase I, Open-Label, Pharmacokinetic, Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset SeizuresStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Open-Label Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) SeizuresStatus: Recruiting, Estimated PCD: 2026-05-01
Clinical trial
A Double-blind, Randomized, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Ganaxolone as add-on Therapy in Adult Subjects With Epilepsy Consisting of Uncontrolled Partial-onset Seizures.Status: Completed, Estimated PCD: 2008-10-01
Product
GanaxoloneClinical trial
An Open Label, Multicenter, Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset SeizuresStatus: Completed, Estimated PCD: 2021-03-31
Product
YKP3089